Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C4C1 | ISIN: NO0010692130 | Ticker-Symbol: 8V8
Frankfurt
06.06.25 | 08:01
0,064 Euro
-9,86 % -0,007
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
GENETIC ANALYSIS AS Chart 1 Jahr
5-Tage-Chart
GENETIC ANALYSIS AS 5-Tage-Chart

Aktuelle News zur GENETIC ANALYSIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoGENETIC ANALYSIS AS: Today the subscription period in Genetic Analysis subsequent offering begins1
DiGENETIC ANALYSIS AS: Genetic Analysis first day of trading excluding subscription rights2
DiXFRA CAPITAL ADJUSTMENT INFORMATION - 03.06.2025136Das Instrument TGNA FR0005175080 TRANSGENE SA EO 0,50 EQUITY wird cum Kapitalmassnahme gehandelt am 03.06.2025 und ex Kapitalmassnahme am 04.06.2025 The instrument TGNA FR0005175080 TRANSGENE SA EO...
► Artikel lesen
MoGENETIC ANALYSIS AS: Genetic Analysis publishes Simplified disclosure document relating to the previously announced subsequent offering4
MoSpotlight Stock Market: Market Notice 99/25 - Information regarding the rights issue from Genetic Analysis AS2
GENETIC ANALYSIS Aktie jetzt für 0€ handeln
MoGENETIC ANALYSIS AS: Genetic Analysis Last day of trading including subscription rights2
27.05.GENETIC ANALYSIS AS: Correction: Publication of Q1 report January - March 20252
27.05.GENETIC ANALYSIS AS: Genetic Analysis announces details of Subsequent Offering following directed issue2
27.05.GENETIC ANALYSIS AS: Publication of Q1 report January - March 20252
20.05.Genetic Analysis AS: Mandatory notification of trade1
20.05.Minutes from the Annual General Meeting 2024 in Genetic Analysis AS3
05.05.GENETIC ANALYSIS AS: Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million1
05.05.GENETIC ANALYSIS AS: Genetic Analysis announces proposed changes to the Board1
05.05.GENETIC ANALYSIS AS: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million1
05.05.GENETIC ANALYSIS AS: Notice of annual general meeting1
02.05.Genetic Analysis AS publishes Annual Report 20241
22.04.Genetic Analysis AS and Thalys Medical Technology Group are pleased to announce the launch of a microbiome test to the Chinese Consumer Health market1
26.02.Genetic Analysis AS publishes year-end report 20241
20.12.24Genetic Analysis AS: Genetic Analysis And Ferring Pharmaceuticals Announce A Collaboration To Develop A New Microbiome Rapid Diagnostic Test1
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1